CP, a cysteine protease, is released in the majority of malignancies and directly cleaves Factor X → Xa, independent of FVII, resulting in thrombin generation, and 85% of cancer patients were shown to have elevated levels of CP, implicating its role in creating a procoagulant state for cancer patients [59]. Here, TNXA is linked to cancer.